|
Revascularization
Citations 211-220 of 245 total displayed.
|
Past content
(since Jun 1998):
|
- Original Contributions
Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention: REPLACE-2 Randomized Trial
- A. Michael Lincoff; John A. Bittl; Robert A. Harrington; Frederick Feit; Neal S. Kleiman; J. Daniel Jackman; Ian J. Sarembock; David J. Cohen; Douglas Spriggs; Ramin Ebrahimi; Gadi Keren; Jeffrey Carr; Eric A. Cohen; Amadeo Betriu; Walter Desmet; Dean J. Kereiakes; Wolfgang Rutsch; Robert G. Wilcox; Pim J. de Feyter; Alec Vahanian; Eric J. Topol; for the REPLACE-2 Investigators
JAMA 2003; 289: 853-863.
[Abstract]
[Full text]
[PDF]
[ Corrected PDF ]
- Editorials
Should Bivalirudin Replace Heparin During Percutaneous Coronary Interventions?
- Elliott M. Antman
JAMA 2003; 289: 903-905.
[Extract]
[Full text]
[PDF]
- Clinical Cardiology
Use of Low-Molecular-Weight Heparins in the Management of Acute Coronary Artery Syndromes and Percutaneous Coronary Intervention
- Graham C. Wong; Robert P. Giugliano; Elliott M. Antman
JAMA 2003; 289: 331-342.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Benefit of an Early Invasive Management Strategy in Women With Acute Coronary Syndromes
- Ruchira Glaser; Howard C. Herrmann; Sabina A. Murphy; Laura A. Demopoulos; Peter M. DiBattiste; Christopher P. Cannon; Eugene Braunwald
JAMA 2002; 288: 3124-3129.
[Abstract]
[Full text]
[PDF]
- Editorials
Acute Coronary Syndromes: Does Sex Matter?
- Judith S. Hochman; Jacqueline E. Tamis-Holland
JAMA 2002; 288: 3161-3164.
[Extract]
[Full text]
[PDF]
- Original Contributions
Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Randomized Controlled Trial
- Steven R. Steinhubl; Peter B. Berger; J. Tift Mann III; Edward T. A. Fry; Augustin DeLago; Charles Wilmer; Eric J. Topol; for the CREDO Investigators
JAMA 2002; 288: 2411-2420.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Cost and Cost-effectiveness of an Early Invasive vs Conservative Strategy for the Treatment of Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction
- Elizabeth M. Mahoney; Claudine T. Jurkovitz; Haitao Chu; Edmund R. Becker; Steven Culler; Andrzej S. Kosinski; Debbie H. Robertson; Charles Alexander; Soma Nag; John R. Cook; Laura A. Demopoulos; Peter M. DiBattiste; Christopher P. Cannon; William S. Weintraub; for the TACTICS-TIMI 18 Investigators
JAMA 2002; 288: 1851-1858.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Mortality in Medicare Beneficiaries Following Coronary Artery Bypass Graft Surgery in States With and Without Certificate of Need Regulation
- Mary S. Vaughan-Sarrazin; Edward L. Hannan; Carol J. Gormley; Gary E. Rosenthal
JAMA 2002; 288: 1859-1866.
[Abstract]
[Full text]
[PDF]
- Editorials
Invasive vs Conservative Management of Acute Coronary Syndromes: Do the Data Support the Guidelines?
- David J. Cohen
JAMA 2002; 288: 1905-1907.
[Extract]
[Full text]
[PDF]
- Original Contributions
Fluvastatin for Prevention of Cardiac Events Following Successful First Percutaneous Coronary Intervention: A Randomized Controlled Trial
- Patrick W. J. C. Serruys; Pim de Feyter; Carlos Macaya; Norbert Kokott; Jacques Puel; Matthias Vrolix; Angelo Branzi; Marcelo C. Bertolami; Graham Jackson; Bradley Strauss; Bernhard Meier; for the Lescol Intervention Prevention Study Investigators
JAMA 2002; 287: 3215-3222.
[Abstract]
[Full text]
[PDF]
|
|
